We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




New Laparoscopic System Makes Trocar Use Redundant

By HospiMedica International staff writers
Posted on 29 Mar 2015
A novel percutaneous surgical system does not require introductory trocars, thus leaving only a tiny mark on the patient’s skin following the procedure.

The Percuvance Percutaneous Surgical System is a micro-laparoscopic platform that is comprised of nine unique components, combined in various configurations to create a multifunctional set of instruments for laparoscopic procedures. More...
It is based on a shaft with a diameter of 2.9 mm diameter, which is inserted percutaneously using a Veress introducer needle tip. It can then be connected extracorporeally via a reusable handle to a wide variety of interchangeable five-mm (full size) end effector surgical tool tips, including Metzenbaum scissors, Gripper grasper, Johans grasper, and a Maryland dissector.

The smaller diameter shaft is still sufficiently strong to hold structures while the surgeon uses the interchangeable tool tips to grasp, cut, and manipulate tissue. A proprietary seal bridge, available in two sizes (5 mm and 12 mm), is used to protect the seal and to aid in maintaining insufflation, as well as to facilitate the extracorporeal exchange of the end effectors. In addition, procedures using the Percuvance System require fewer trocars and cause less trauma and better cosmesis during healing.

Additional benefits include a short surgeon learning curve with fewer adjustments necessary to the surgeons’ current techniques, as well as an institutional saving on the costs associated with capital, service, and fully disposable technologies. The Percuvance Percutaneous Surgical System is a product of Teleflex (Limerick, PA, USA), and has been approved by the US Food and Drug Administration (FDA) and has also received the European Community CE marking of approval.

The Percuvance System complements another Teleflex product, the MiniLap Percutaneous Surgical System, which provides delivery and function through an integrated, disposable 2.3-mm device. Like the Percuvance System, the MiniLap System does not require a trocar and makes minimally invasive laparoscopic procedures less invasive.

Related Links:

Teleflex
Teleflex Percuvance video



Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Adjustable Mobile Barrier
M-458
Radiation Safety Barrier
RayShield Intensi-Barrier
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.